Revvity, Inc. launched new discovery platforms at SLAS2026, including the Opera Phenix OptIQ™ high-content screening system, the EnVision Nexus™ One multimode plate reader, and the AssayMate™ workstation. These innovations aim to accelerate high-throughput drug discovery workflows, spanning sample preparation, screening, advanced imaging, and lab automation. The new technologies are designed to address bottlenecks in phenotypic screening and enhance data quality and automation for various laboratory needs.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026
Revvity, Inc. launched new discovery platforms at SLAS2026, including the Opera Phenix OptIQ™ high-content screening system, the EnVision Nexus™ One multimode plate reader, and the AssayMate™ workstation. These innovations aim to accelerate high-throughput drug discovery workflows, spanning sample preparation, screening, advanced imaging, and lab automation. The new technologies are designed to address bottlenecks in phenotypic screening and enhance data quality and automation for various laboratory needs.